BioSyent Inc. announced a quarterly dividend of CAD 0.055 per common share for the second quarter of 2026, payable on June 15, 2026, to shareholders recorded by May 29, 2026. This dividend is consistent with the first quarter's payout and qualifies as an 'eligible dividend' for Canadian tax purposes. The company's board retains discretion over future dividend decisions. BioSyent is a specialty healthcare products company listed on the TSX Venture Exchange, focusing on pharmaceutical and oral health products in Canada and internationally.
Research presented at the 2026 American Urological Association Annual Meeting reveals progress in bladder cancer treatment and prevention. Key findings include an immunotherapy drug, durvalumab, combined with standard BCG treatment, which delays dise...
The Law Offices of Howard G. Smith has issued a reminder for investors in Stellantis, United Homes Group, LKQ Corporation, and Globant about upcoming deadlines to file lead plaintiff motions in securities fraud class actions. These lawsuits allege th...
US stock markets declined on Friday due to rising oil prices and a bond market sell-off, which increased fears of interest rate hikes by the Federal Reserve. The 10-year Treasury yield hit its highest level in a year, and traders now expect no rate c...
DexCom outlined its long-term growth vision, expecting over 10% annual organic revenue growth through 2030. The company aims for a 67-69% adjusted gross profit margin and a 29-30% adjusted operating profit margin by 2030. DexCom also approved a new $...
Trasteel Holding S.A. and Al Qalaa International Group have established a 50-50 joint venture named QTrasteel to enhance trading, project development, and industrial services across the Middle East and North Africa (MENA) region. This partnership lev...
